---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-019325"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:26:22.219388+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nutex Health receives second 180-day Nasdaq compliance period for bid price deficiency

## Summary
- Company failed to regain minimum $1 bid price by Nov 20, 2023 initial deadline.
- Nasdaq grants additional period until May 20, 2024 to cure the deficiency.
- Company may effect a reverse stock split if needed, no later than 10 business days before deadline.
- No immediate impact on common stock listing or trading at this time.
- Failure to cure by May 20, 2024 could lead to delisting and potential appeal to Nasdaq Hearings Panel.

## SEC filing metadata
- accession: 0001558370-23-019325
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837023019325/0001558370-23-019325-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837023019325/nutx-20231121x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-019325
- JSON: https://secwatch.observer/filing/0001558370-23-019325.json
- Plain text: https://secwatch.observer/filing/0001558370-23-019325.txt

## Key facts
- Listing & Compliance Notices
  Nutex Health Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: May 22, 2023, Nutex Health Inc. (the “Company”) received a letter (the “First Nasdaq Bid Price Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for thirty consecutive business days prior to the date of such letter, the bid price for the Company’s common stock (the “Common Stock”) had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar d
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837023019325/0001558370-23-019325-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.